NCT04028063 2026-04-20
Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas
University of Colorado, Denver
Phase 2 Active not recruiting
University of Colorado, Denver
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Weill Medical College of Cornell University
Agenus Inc.